← Leaderboards
Jr R Lemanske
University Of Wisconsin Madison
$1,155,985
Attributed
$1,155,985
Total exposure
5
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,155,985 · 5
By mechanism
M01$1,155,985 · 5
Top collaborators
No co-investigators on record.
Most similar at University Of Wisconsin Madison
Same institution · by research overlap
- Robert F Lemanske$29,535,752
- Michael M Altaweel$4,628,844
- William W. Busse$100,295,147
- Heather C Abercrombie$3,013,730
- Paul Leon Kaufman$13,620,480
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchAsthmaHuman SubjectDrug Screening /EvaluationCorticosteroidsRespiratory Disorder ChemotherapyInhalation Drug AdministrationHuman Therapy EvaluationRespiratory TherapyAntiinflammatory AgentsHormone TherapyDosageDrug Adverse EffectInterferon GammaPathologic ProcessBlood ChemistryBronchodilatorsChild (0-11)Clinical Trial Phase ICortisolCytokineDisease /Disorder EtiologyImmunoregulationImmunosuppression
Grant awards (23)
SALMETEROL PLUS/MINUS INHALED CORTICOSTEROIDS--SLIC PROTOCOL$106,600
M01 · FY2002 · RR
CYTOKINE DYSREGULATION, VIRUSES, &CHILDHOOD ASTHMA$106,600
M01 · FY2002 · RR
DOSE OF INHALED CORTICOSTEROIDS W/ EQUISYSTEMIC EFFECTS (DICE)$106,600
M01 · FY2002 · RR
DOSE OF INHALED CORTICOSTEROID WITH EQUISYSTEMIC EFFECTS (DICE)--PILOT STUDY$106,600
M01 · FY2002 · RR
COMPARISON OF INHALED CORTICOSTERIOD, LONG LASTING BETA AGONIST, AND PLACEBO$106,600
M01 · FY2002 · RR
COMPARISON OF INHALED CORTICOSTERIOD, LONG LASTING BETA AGONIST, AND PLACEBO$106,600
M01 · FY2001 · RR
SALMETEROL PLUS/MINUS INHALED CORTICOSTEROIDS--SLIC PROTOCOL$106,600
M01 · FY2001 · RR
DOSE OF INHALED CORTICOSTEROID WITH EQUISYSTEMIC EFFECTS (DICE)--PILOT STUDY$106,600
M01 · FY2001 · RR
DOSE OF INHALED CORTICOSTEROIDS W/ EQUISYSTEMIC EFFECTS (DICE)$106,600
M01 · FY2001 · RR
CYTOKINE DYSREGULATION, VIRUSES, &CHILDHOOD ASTHMA$106,600
M01 · FY2001 · RR
COMPARISON OF INHALED CORTICOSTERIOD, LONG LASTING BETA AGONIST, AND PLACEBO$12,855
M01 · FY2001 · RR
DOSE OF INHALED CORTICOSTEROID WITH EQUISYSTEMIC EFFECTS (DICE)--PILOT STUDY$12,855
M01 · FY2001 · RR
DOSE OF INHALED CORTICOSTEROIDS W/ EQUISYSTEMIC EFFECTS (DICE)$12,855
M01 · FY2001 · RR
CYTOKINE DYSREGULATION, VIRUSES, &CHILDHOOD ASTHMA$12,855
M01 · FY2001 · RR
SALMETEROL PLUS/MINUS INHALED CORTICOSTEROIDS--SLIC PROTOCOL$12,855
M01 · FY2001 · RR
SALMETEROL PLUS/MINUS INHALED CORTICOSTEROIDS--SLIC PROTOCOL$12,855
M01 · FY2000 · RR
DOSE OF INHALED CORTICOSTEROID WITH EQUISYSTEMIC EFFECTS (DICE)--PILOT STUDY$12,855
M01 · FY2000 · RR
DOSE OF INHALED CORTICOSTEROIDS W/ EQUISYSTEMIC EFFECTS (DICE)$0
M01 · FY2000 · RR
DOSE OF INHALED CORTICOSTEROIDS W/ EQUISYSTEMIC EFFECTS (DICE)$0
M01 · FY2000 · RR
CYTOKINE DYSREGULATION, VIRUSES, &CHILDHOOD ASTHMA$0
M01 · FY2000 · RR
CYTOKINE DYSREGULATION, VIRUSES, &CHILDHOOD ASTHMA$0
M01 · FY2000 · RR
COMPARISON OF INHALED CORTICOSTERIOD, LONG LASTING BETA AGONIST, AND PLACEBO$0
M01 · FY2000 · RR
COMPARISON OF INHALED CORTICOSTERIOD, LONG LASTING BETA AGONIST, AND PLACEBO$0
M01 · FY2000 · RR